Huarong Chemical Co., Ltd. (SHE:301256)
China · Delayed Price · Currency is CNY 15.78
-0.43 (-2.65%)
At close: Feb 12, 2026
Huarong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,637 | 1,197 | 1,051 | 1,132 | 641.21 | 937.41 |
Other Revenue | 9.84 | 9.84 | 8.07 | 2.96 | 3.17 | 8.62 |
| 1,647 | 1,206 | 1,059 | 1,135 | 644.38 | 946.03 | |
Revenue Growth (YoY) | 45.36% | 13.89% | -6.67% | 76.14% | -31.89% | -8.50% |
Cost of Revenue | 1,481 | 1,022 | 874.55 | 950.02 | 484.66 | 749.83 |
Gross Profit | 166.16 | 184.35 | 184.77 | 184.99 | 159.73 | 196.2 |
Selling, General & Admin | 59.86 | 69.25 | 69.14 | 57.39 | 42.86 | 52.46 |
Research & Development | 39.29 | 46.37 | 51.71 | 8.68 | 10.1 | 8.97 |
Other Operating Expenses | 9.75 | 8.06 | 8.84 | 9.01 | 5.09 | 6.95 |
Operating Expenses | 109.16 | 124.12 | 131.29 | 75.87 | 58.87 | 68.21 |
Operating Income | 57 | 60.23 | 53.49 | 109.12 | 100.86 | 127.99 |
Interest Expense | -5.87 | -9.45 | -11.44 | -4.82 | -1.21 | -4.17 |
Interest & Investment Income | 34.32 | 49.8 | 104.06 | 29.28 | 6.02 | 4.52 |
Currency Exchange Gain (Loss) | 0.35 | 0.35 | 10.87 | 3.39 | -0.16 | -0.57 |
Other Non Operating Income (Expenses) | -0.55 | -0.63 | -0.56 | -0.29 | -0.09 | 0.3 |
EBT Excluding Unusual Items | 85.26 | 100.31 | 156.42 | 136.68 | 105.43 | 128.08 |
Gain (Loss) on Sale of Investments | 0.13 | 0.05 | 0.79 | 0.08 | - | - |
Gain (Loss) on Sale of Assets | 1.97 | 2.07 | -0.83 | - | 7.72 | -0.38 |
Asset Writedown | -0.69 | - | - | -0.03 | - | -7.07 |
Other Unusual Items | 15.26 | 12.45 | 3.4 | 5.56 | 5.46 | 1.92 |
Pretax Income | 101.93 | 114.87 | 159.79 | 142.29 | 118.6 | 122.55 |
Income Tax Expense | 12.32 | 14.37 | 21.11 | 20.14 | 16.72 | 19.26 |
Net Income | 89.61 | 100.5 | 138.67 | 122.15 | 101.88 | 103.29 |
Net Income to Common | 89.61 | 100.5 | 138.67 | 122.15 | 101.88 | 103.29 |
Net Income Growth | -8.90% | -27.53% | 13.53% | 19.90% | -1.37% | 3.99% |
Shares Outstanding (Basic) | 479 | 479 | 478 | 452 | 364 | 356 |
Shares Outstanding (Diluted) | 479 | 479 | 478 | 452 | 364 | 356 |
Shares Change (YoY) | 0.09% | 0.08% | 5.70% | 24.34% | 2.15% | 3.99% |
EPS (Basic) | 0.19 | 0.21 | 0.29 | 0.27 | 0.28 | 0.29 |
EPS (Diluted) | 0.19 | 0.21 | 0.29 | 0.27 | 0.28 | 0.29 |
EPS Growth | -8.97% | -27.59% | 7.41% | -3.57% | -3.45% | - |
Free Cash Flow | -92.09 | -55.78 | -10.33 | 80.53 | -38.14 | 30.2 |
Free Cash Flow Per Share | -0.19 | -0.12 | -0.02 | 0.18 | -0.10 | 0.09 |
Dividend Per Share | 0.160 | 0.170 | 0.200 | 0.080 | 0.050 | - |
Dividend Growth | -36.00% | -15.00% | 150.00% | 60.00% | - | - |
Gross Margin | 10.09% | 15.28% | 17.44% | 16.30% | 24.79% | 20.74% |
Operating Margin | 3.46% | 4.99% | 5.05% | 9.61% | 15.65% | 13.53% |
Profit Margin | 5.44% | 8.33% | 13.09% | 10.76% | 15.81% | 10.92% |
Free Cash Flow Margin | -5.59% | -4.62% | -0.97% | 7.09% | -5.92% | 3.19% |
EBITDA | 89.91 | 90.07 | 79.25 | 127.71 | 113.14 | 142.33 |
EBITDA Margin | 5.46% | 7.47% | 7.48% | 11.25% | 17.56% | 15.04% |
D&A For EBITDA | 32.91 | 29.85 | 25.77 | 18.59 | 12.28 | 14.34 |
EBIT | 57 | 60.23 | 53.49 | 109.12 | 100.86 | 127.99 |
EBIT Margin | 3.46% | 4.99% | 5.05% | 9.61% | 15.65% | 13.53% |
Effective Tax Rate | 12.08% | 12.51% | 13.21% | 14.15% | 14.10% | 15.72% |
Revenue as Reported | 1,647 | 1,206 | 1,059 | 1,135 | - | 946.03 |
Advertising Expenses | - | 0.04 | 0.77 | 0 | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.